The overall market for frontotemporal dementia is expected to grow with the anticipated launch of emerging therapies, including Latozinemab, PBFT02, TAK-594/DNL593, and others, increased awareness, and extensive research in the forecast period (2025–2034). LAS VEGAS, July 1, 2025...
Frontotemporal Dementia Market Sees Rise in Precision Medicine and Gene Therapy Approaches | DelveInsight
Seeking Alpha / 13 hours ago 3 Views
Comments